The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The impact of tumor molecular profile-directed treatment on survival in recurrent ovarian cancer.
Kate Eleanor Oliver
No relevant relationships to disclose
Nianqing Xiao
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
David Spetzler
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Neil T. Phippen
No relevant relationships to disclose
Ryan T Oleszewski
No relevant relationships to disclose
William P. McGuire
No relevant relationships to disclose